Michael Kyriakides

Director/Board Member at

Purespring Therapeutics Ltd.

Consumer Services

Finance

Health Technology

Profile

Michael Kyriakides is a Board Member at Purespring Therapeutics Ltd. since 2022.
Formerly, Mr. Kyriakides was an Investment Partner at Syncona Partners LLP.
Mr. Kyriakides completed undergraduate, graduate, and doctorate degrees at Imperial College London in 2010, 2011, and 2014 respectively.

Michael Kyriakides active positions

Companies	Position	Start
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Director/Board Member	2022-03-31

All active positions of Michael Kyriakides

Former positions of Michael Kyriakides

Companies	Position	End
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Private Equity Investor	-

See the detail of Michael Kyriakides's experience

Training of Michael Kyriakides

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Kyriakides's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Imperial College London Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syncona Partners LLP Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements.	Finance
Purespring Therapeutics Ltd. Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases	Health Technology